GLI3 and cancer: On the other hand, the NMIBC patients receiving Bacillus Calmette-Guerin treatment who carried the GLI3 SNPs rs3801192 and rs6463089 were found to have a higher cancer recurrence rate and shorter recurrence-free survival time compared to those carrying the wildtype genotype.